Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-27 Sale |
2025-02-28 8:35 pm |
EXELIXIS INC. | EXEL | Smith Julie Director |
73,808 | $38 | $2,804,459 | 30,072 (Direct) |
View |
| 2024-05-21 Sale |
2024-05-23 6:55 pm |
EXELIXIS INC. | EXEL | Smith Julie Director |
27,280 | $21.12 | $576,154 | 5,445 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-27 Exercise |
2025-02-28 8:35 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Smith Julie Director |
42,641 | $19.77 | 30,072 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 8:35 pm |
2018-05-24 2025-05-23 |
EXELIXIS INC. | EXEL | Smith Julie Director |
73,808 | $0 | 30,072 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 8:35 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Smith Julie Director |
31,167 | $20.5 | 30,072 (Direct) |
View |
| 2024-08-13 Other |
2024-08-15 8:18 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Smith Julie Director |
4,682 | $0 | 15,460 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:27 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
7,639 | $0 | 7,639 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 8:19 pm |
2024-05-31 2031-05-30 |
EXELIXIS INC. | EXEL | Smith Julie Director |
30,045 | $0 | 35,490 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:26 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
19,441 | $0 | 19,441 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 9:10 pm |
2023-06-01 2030-05-31 |
EXELIXIS INC. | EXEL | Smith Julie Director |
44,087 | $0 | 44,087 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 9:12 pm |
2022-05-26 2029-05-25 |
EXELIXIS INC. | EXEL | Smith Julie Director |
42,422 | $0 | 42,422 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 5:02 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 8:08 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Smith Julie Director |
16,424 | $0 | 32,725 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 5:31 pm |
N/A 2020-06-02 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
29,555 | $0 | 29,555 (Direct) |
View |
Ownership |
2020-06-05 5:10 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
0 | $0 | 0 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-22 9:06 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Smith Julie Director |
15,538 | $0 | 16,301 (Direct) |
View |